Gene amplification refers to increase in amount of a specific DNA from a very small volume. Growth in the global market is being spurred by increase in demand for the collection of genetic data for identification as well as mapping of all human genome genes.
The extensive adoption for certain cancer treatments is driving the global gene amplification technology market. The most important driver for the growth of the market for gene amplification technologies have remained Human Genome Projects (HGP).
Another key driver shaping the growth remains molecular diagnostics that provide insight in uncovering particular sequences in RNA or DNA for the possibility of association with any kind of disease. Other factors that are shaping the growth of the market are increased focus on drug discovery, R&D in the molecular diagnostic field, toxicology, genetic testing, animal husbandry, environmental monitoring, quality assurance in the industry for food products, forensics, and bioremediation.
Amid the COVID-19 crisis, the global market for Gene Amplification Technologies estimated at US$4.6 Billion in the year 2022, is projected to reach a revised size of US$6.4 Billion by 2026, growing at a CAGR of 11.4% over the analysis period.
